Search details
1.
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.
N Engl J Med
; 387(16): 1445-1455, 2022 10 20.
Article
in English
| MEDLINE | ID: mdl-36260792
2.
Reliability and agreement testing of a new automated measurement method to determine facial vitiligo extent using standardized ultraviolet images and a dedicated algorithm.
Br J Dermatol
; 190(1): 62-69, 2023 Dec 20.
Article
in English
| MEDLINE | ID: mdl-37615581
3.
Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial.
J Am Acad Dermatol
; 88(2): 395-403, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36370907
4.
Prevalence of Vitiligo among Children and Adolescents in the United States.
Dermatology
; 239(2): 227-234, 2023.
Article
in English
| MEDLINE | ID: mdl-36630928
5.
Clinician-reported outcome measures for the assessment of vitiligo: A scoping review.
J Eur Acad Dermatol Venereol
; 37(11): 2231-2242, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37602494
6.
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force-Part 2: Specific treatment recommendations.
J Eur Acad Dermatol Venereol
; 37(11): 2185-2195, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37715487
7.
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm.
J Eur Acad Dermatol Venereol
; 37(11): 2173-2184, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37746876
8.
Efficacy of a lay community health worker (promotoras de salud) program to improve adherence to emollients in Spanish-speaking Latin American pediatric patients in the United States with atopic dermatitis: A randomized, controlled, evaluator-blinded study.
Pediatr Dermatol
; 40(1): 69-77, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36263875
9.
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial.
Lancet
; 396(10244): 110-120, 2020 07 11.
Article
in English
| MEDLINE | ID: mdl-32653055
10.
Standardizing serial photography for assessing and monitoring vitiligo: A core set of international recommendations for essential clinical and technical specifications.
J Am Acad Dermatol
; 83(6): 1639-1646, 2020 Dec.
Article
in English
| MEDLINE | ID: mdl-31678332
11.
Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
Australas J Dermatol
; 61(3): 237-242, 2020 Aug.
Article
in English
| MEDLINE | ID: mdl-32109318
12.
A retrospective cross-sectional analysis of gender and racial/ethnic diversity trends in dermatology chairs.
J Am Acad Dermatol
; 2024 May 17.
Article
in English
| MEDLINE | ID: mdl-38763289
13.
Disorders of Hypopigmentation
J Drugs Dermatol
; 18(3): s115-s116, 2019 Mar 01.
Article
in English
| MEDLINE | ID: mdl-30909355
14.
Diversity in dermatology: Roadmap for improvement.
J Am Acad Dermatol
; 79(2): 337-341, 2018 Aug.
Article
in English
| MEDLINE | ID: mdl-29653209
15.
Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma.
J Am Acad Dermatol
; 78(2): 363-369, 2018 02.
Article
in English
| MEDLINE | ID: mdl-28987494
16.
Consensus on the safety and risks of laser and intense pulse light treatments in patients with vitiligo: An e-Delphi study.
J Am Acad Dermatol
; 89(2): 352-354, 2023 08.
Article
in English
| MEDLINE | ID: mdl-36967022
17.
Oral Tranexamic Acid for the Treatment of Melasma: A Review.
Dermatol Surg
; 44(6): 814-825, 2018 Jun.
Article
in English
| MEDLINE | ID: mdl-29677015
18.
Commentary on vitiligo patient population and disease burden in France: VIOLIN Study results from the CONSTANCES cohort.
J Eur Acad Dermatol Venereol
; 37(11): 2159-2160, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37877764
19.
Noticeability of vitiligo is in the eye of the beholder.
Br J Dermatol
; 187(4): 461-462, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35905981
20.
Impact of nonsegmental vitiligo on patients' health-related quality of life in the United States.
Br J Dermatol
; 187(4): 603-606, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35596712